Research guide · Cellular Energy
VIP — research protocol
Vasoactive Intestinal Peptide studied for neuroimmune modulation, vasodilation and anti-inflammatory pathways.
This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.
Catalog presentations
Concentration table
Mathematical reference only; this is not a dosing recommendation.
Research areas
- 28-amino-acid neuropeptide
- Neuroimmune compound
- 99% HPLC verified purity
Most-cited research protocols
Educational information based on research protocols and literature; it does not replace guidance from a healthcare professional.
VIP (Vasoactive Intestinal Peptide) is a natural 28-amino acid neuropeptide that relaxes smooth muscle, widens blood vessels, and calms inflammation. This summary focuses on its use in subcutaneous research vials and compounded intranasal sprays.
| Dose | Frequency | Duration | Route | |
|---|---|---|---|---|
| Conservative Start | 50 mcg | Once daily | 1-2 weeks | SubQ |
| Standard Research Dose | 100 mcg | 1-2x daily | Ongoing | SubQ |
| Advanced Research Dose | 200 mcg | 1-2x daily | Ongoing | SubQ |
| Clinic-Style Protocol (SubQ) | 200 mcg | 5x weekly | Ongoing | SubQ |
Cycle: Not typically used, no standardized cycling protocol; continuous administration is a common approach, aiming for the lowest effective dose for maintenance.
Benefits and research observations: Monitor lipase and symptoms; in clinic settings, lipase is rechecked after the first dose, around two weeks in, and after any dose increase. No strong trial evidence shows a predictable benefit timeline for most uses.
Handling and storage
Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.
Warnings
Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.
Published sources
- 1.Delgado M, Ganea D. Amino Acids, 2013.
- 2.Gonzalez-Rey E, et al. Nat Rev Immunol, 2007.